Article By:
ChinaBio® Today
Saturday, December 31, 2022 2:30 PM EDT
China Biopharma deal activity in 2022 was certainly slower than the previous year, but the ten largest deals, many of them booked in the second half of the year, totaled a decent $21.5 billion by themselves.